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The present invention provides a new drug to treat malignant glioma, which is
the most prevalent type of primary tumor of the central nervous system (CNS).
The present invention indeed shows that the isolated NFL-TBS40-63 peptide is
highly specific for glioma cells, in which it triggers apoptosis. It is therefore
presented here for use in a method for treating malignant glioma. The present
invention further relates to the use of the NFL-TBS40-63 peptide for detecting
specifically glioma cells either in vivo, or in vitro, or for addressing chemical
compounds to said tumor cells.
URL de la notice http://okina.univ-angers.fr/publications/ua9048 [5]







Publié sur Okina (http://okina.univ-angers.fr)
